Kelly Holloway
Biographic Data
| ID | 3927022 |
|---|---|
| NAME | Kelly Holloway |
| GIVEN NAMES | Kelly |
| FAMILY NAME | Holloway |
| SIGNATURE | HOLLOWAY K |
| AFFILIATIONS | Canadian Blood Services |
| ORCID | 0000-0003-3867-1072 |
| VERIFIED | Yes |
| TOTAL WORKS | 14 |
| TOTAL CITATIONS | 17 |
| AUTHOR COUNT | 14 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 2 |
Engaging patients in blood systems: A qualitative study on immune globulin recipient perspectives
Understanding systemic barriers to blood donation for people of South Asian ancestry: A qualitative study
We explored how South Asian communities in the Greater Toronto Area (GTA) understand and experience blood donation, systemic barriers to donation, and offer recommendations for blood operators to foster inclusivity and equity in blood donation systems. Using a community-based participatory research approach, we conducted semi-structured interviews with 10 community leaders of South Asian ancestry. Reflexive thematic analysis was used to identify …
Developing a social model for blood and plasma donation
Chaos, miracle, and coping: A narrative analysis of immunoglobulin recipients’ lived experiences of illness, diagnosis and treatment
The plasma-derived medical products in highest demand is immunoglobulin (Ig). • This study is a narrative analysis of Ig recipients in Canada. • Patients with immunodeficiencies and polyneuropathies struggle to receive a diagnosis. • Patients' experiences of this treatment are situated within their social lives. • Ig can have a meaningful impact on the lives of people with these illnesses
Emotional Labor of Nurses and Phlebotomists in a New Source Plasma Collection Site During the Covid-19 Pandemic
As uses of plasma-derived medical products increase globally, so does the demand to collect plasma from donors. There is evidence that positive interactions with center staff motivate plasma donors to return. This paper reports on a focused ethnography investigating experiences of nurses and phlebotomists in one of Canadian Blood Services' first source plasma collection center during the COVID-19 pandemic. Participants found the transition from w…
Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of Covid-19
COVID-19 has posed unprecedented challenges to health systems around the world, including blood collection agencies (BCAs). Many countries, such as Canada and Australia, that rely on non-remunerated voluntary donors saw an initial drop in donors in the early days of the pandemic followed by a return to sufficient levels of the blood supply. BCA messaging plays a key role in communicating the needs of the blood operator, promoting and encouraging …
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility
The potential for bias in industry‐developed information about noninvasive prenatal testing (NIPT), in addition to the lack of regulatory oversight for this type of product, raises questions about clinical communication and adoption. We identify NIPTs marketed globally and analyze their English‐language consumer‐oriented brochures to determine whether they meet existing policy and ethical guidance from the Nuffield Council on Bioethics on NIPT ma…
The Consultant's intermediary role in the regulation of molecular diagnostics in the US
Withdrawn: Payment and profit in Canada's plasma collection system: a process evaluation of Canadian Blood Services effort to meet sufficiency
Industry, experts and the role of the 'invisible college' in the dissemination of non-invasive prenatal testing in the US
A responsibility to commercialize? Tracing academic researchers’ evolving engagement with the commercialization of biomedical research
Governments and academic institutions have embraced the importance of commercializing research through the late twentieth century. In this study, we seek to understand scientists’ contemporary understanding of the role of academic science in this commercially oriented environment. We present findings based on 30 semi-structured interviews with biomedical researchers from different career stages at a medium-sized university in Canada about patenti…
Normalizing Complaint: Scientists and the Challenge of Commercialization
In recent decades, academic science has increasingly been directed toward commercializable ends by neoliberal governments. In this article, I outline a concern that academic scientists have not been consulted about the transformation of science, but nevertheless, in some ways accept commercialization as the way things are done. I focus on the ways in which academic scientists attempt to exercise agency, albeit within the parameters of the neolibe…
Uneasy subjects: Medical students' conflicts over the pharmaceutical industry
Something there is that doesn’t love a wall’: Histories of the placental barrier
Normalizing Complaint: Scientists and the Challenge of Commercialization
In recent decades, academic science has increasingly been directed toward commercializable ends by neoliberal governments. In this article, I outline a concern that academic scientists have not been consulted about the transformation of science, but nevertheless, in some ways accept commercialization as the way things are done. I focus on the ways in which academic scientists attempt to exercise agency, albeit within the parameters of the neolibe…
Something there is that doesn’t love a wall’: Histories of the placental barrier
The Consultant's intermediary role in the regulation of molecular diagnostics in the US
Uneasy subjects: Medical students' conflicts over the pharmaceutical industry
Industry, experts and the role of the 'invisible college' in the dissemination of non-invasive prenatal testing in the US
Something there is that doesn’t love a wall’: Histories of the placental barrier
Uneasy subjects: Medical students' conflicts over the pharmaceutical industry
Normalizing Complaint: Scientists and the Challenge of Commercialization
In recent decades, academic science has increasingly been directed toward commercializable ends by neoliberal governments. In this article, I outline a concern that academic scientists have not been consulted about the transformation of science, but nevertheless, in some ways accept commercialization as the way things are done. I focus on the ways in which academic scientists attempt to exercise agency, albeit within the parameters of the neolibe…
A responsibility to commercialize? Tracing academic researchers’ evolving engagement with the commercialization of biomedical research
Governments and academic institutions have embraced the importance of commercializing research through the late twentieth century. In this study, we seek to understand scientists’ contemporary understanding of the role of academic science in this commercially oriented environment. We present findings based on 30 semi-structured interviews with biomedical researchers from different career stages at a medium-sized university in Canada about patenti…
Industry, experts and the role of the 'invisible college' in the dissemination of non-invasive prenatal testing in the US
Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of Covid-19
COVID-19 has posed unprecedented challenges to health systems around the world, including blood collection agencies (BCAs). Many countries, such as Canada and Australia, that rely on non-remunerated voluntary donors saw an initial drop in donors in the early days of the pandemic followed by a return to sufficient levels of the blood supply. BCA messaging plays a key role in communicating the needs of the blood operator, promoting and encouraging …
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility
The potential for bias in industry‐developed information about noninvasive prenatal testing (NIPT), in addition to the lack of regulatory oversight for this type of product, raises questions about clinical communication and adoption. We identify NIPTs marketed globally and analyze their English‐language consumer‐oriented brochures to determine whether they meet existing policy and ethical guidance from the Nuffield Council on Bioethics on NIPT ma…
The Consultant's intermediary role in the regulation of molecular diagnostics in the US
Withdrawn: Payment and profit in Canada's plasma collection system: a process evaluation of Canadian Blood Services effort to meet sufficiency
Emotional Labor of Nurses and Phlebotomists in a New Source Plasma Collection Site During the Covid-19 Pandemic
As uses of plasma-derived medical products increase globally, so does the demand to collect plasma from donors. There is evidence that positive interactions with center staff motivate plasma donors to return. This paper reports on a focused ethnography investigating experiences of nurses and phlebotomists in one of Canadian Blood Services' first source plasma collection center during the COVID-19 pandemic. Participants found the transition from w…
Chaos, miracle, and coping: A narrative analysis of immunoglobulin recipients’ lived experiences of illness, diagnosis and treatment
The plasma-derived medical products in highest demand is immunoglobulin (Ig). • This study is a narrative analysis of Ig recipients in Canada. • Patients with immunodeficiencies and polyneuropathies struggle to receive a diagnosis. • Patients' experiences of this treatment are situated within their social lives. • Ig can have a meaningful impact on the lives of people with these illnesses
Understanding systemic barriers to blood donation for people of South Asian ancestry: A qualitative study
We explored how South Asian communities in the Greater Toronto Area (GTA) understand and experience blood donation, systemic barriers to donation, and offer recommendations for blood operators to foster inclusivity and equity in blood donation systems. Using a community-based participatory research approach, we conducted semi-structured interviews with 10 community leaders of South Asian ancestry. Reflexive thematic analysis was used to identify …
Developing a social model for blood and plasma donation
Engaging patients in blood systems: A qualitative study on immune globulin recipient perspectives
Political science (11 works) · Law (8 works) · Medicine (8 works) · Business (7 works) · Public relations (7 works) · Sociology (7 works) · Blood donation and transfusion practices (6 works) · Psychology (6 works) · Law (5 works) · Engineering (4 works)